OBJECTIVE: The preferred method for screening asymptomatic people for colorectal cancer (CRC) is colonoscopy, according to the new American guidelines. The aim of our study was to perform a meta-analysis of the prospective cohorts using total colonoscopy for screening this population for CRC. We looked for the diagnostic yield of the procedure as well as for its safety in a screening setting. METHODS: We included papers with more than 500 participants and only those reporting diagnostic yield of adenoma (and/or advanced adenoma) and CRC. Nested analysis were performed for secondary endpoints of complications and CRC stages when this information was available. All analyses were performed with StatDirect Statistical software, version 2.6.1 ( http://www.statsdirect.com ). RESULTS: Our search yielded ten studies of screening colonoscopy conducted in asymptomatic people that met our inclusion criteria, with a total of 68,324 participants. Colonoscopy was complete and reached the cecum in 97% of the procedures. Colorectal cancer was found in 0.78% of the participants (95% confidence interval 0.13-2.97%). Stage I or II were found in 77% of the patients with CRC. Advanced adenoma was found in 5% of the cases (95% confidence interval 4-6%). Complications were rare and described in five cohorts. Perforation developed in 0.01% of the cases (95% confidence interval 0.006-0.02%) and bleeding in 0.05% (95% confidence interval 0.02-0.09%). CONCLUSIONS: Our findings support the notion that colonoscopy is feasible and a suitable method for screening for CRC in asymptomatic people.
OBJECTIVE: The preferred method for screening asymptomatic people for colorectal cancer (CRC) is colonoscopy, according to the new American guidelines. The aim of our study was to perform a meta-analysis of the prospective cohorts using total colonoscopy for screening this population for CRC. We looked for the diagnostic yield of the procedure as well as for its safety in a screening setting. METHODS: We included papers with more than 500 participants and only those reporting diagnostic yield of adenoma (and/or advanced adenoma) and CRC. Nested analysis were performed for secondary endpoints of complications and CRC stages when this information was available. All analyses were performed with StatDirect Statistical software, version 2.6.1 ( http://www.statsdirect.com ). RESULTS: Our search yielded ten studies of screening colonoscopy conducted in asymptomatic people that met our inclusion criteria, with a total of 68,324 participants. Colonoscopy was complete and reached the cecum in 97% of the procedures. Colorectal cancer was found in 0.78% of the participants (95% confidence interval 0.13-2.97%). Stage I or II were found in 77% of the patients with CRC. Advanced adenoma was found in 5% of the cases (95% confidence interval 4-6%). Complications were rare and described in five cohorts. Perforation developed in 0.01% of the cases (95% confidence interval 0.006-0.02%) and bleeding in 0.05% (95% confidence interval 0.02-0.09%). CONCLUSIONS: Our findings support the notion that colonoscopy is feasible and a suitable method for screening for CRC in asymptomatic people.
Authors: Maw-Soan Soon; Richard A Kozarek; Kamran Ayub; Anny Soon; Tin-Yu Lin; Otto S Lin Journal: Am J Gastroenterol Date: 2005-12 Impact factor: 10.864
Authors: Raquel E Davila; Elizabeth Rajan; Todd H Baron; Douglas G Adler; James V Egan; Douglas O Faigel; Seng-Ian Gan; William K Hirota; Jonathan A Leighton; David Lichtenstein; Waqar A Qureshi; Bo Shen; Marc J Zuckerman; Trina VanGuilder; Robert D Fanelli Journal: Gastrointest Endosc Date: 2006-04 Impact factor: 9.427
Authors: Amit K Gupta; L Joseph Melton; Gloria M Petersen; Lawrence J Timmons; Santhi Swaroop Vege; William S Harmsen; Nancy N Diehl; Alan R Zinsmeister; David A Ahlquist Journal: Clin Gastroenterol Hepatol Date: 2005-02 Impact factor: 11.382
Authors: Jaroslaw Regula; Maciej Rupinski; Ewa Kraszewska; Marcin Polkowski; Jacek Pachlewski; Janina Orlowska; Marek P Nowacki; Eugeniusz Butruk Journal: N Engl J Med Date: 2006-11-02 Impact factor: 91.245
Authors: Maite Betés Ibáñez; Miguel A Muñoz-Navas; José M Duque; Ramón Angós; Elena Macías; José Carlos Súbtil; Maite Herraiz; Susana de la Riva; Miguel Delgado-Rodríguez; Miguel A Martínez-Gonzélez Journal: Gastrointest Endosc Date: 2004-05 Impact factor: 9.427
Authors: J D Rogge; M F Elmore; S J Mahoney; E D Brown; F P Troiano; D R Wagner; D J Black; D C Pound Journal: Am J Gastroenterol Date: 1994-10 Impact factor: 10.864
Authors: Bernard Levin; David A Lieberman; Beth McFarland; Robert A Smith; Durado Brooks; Kimberly S Andrews; Chiranjeev Dash; Francis M Giardiello; Seth Glick; Theodore R Levin; Perry Pickhardt; Douglas K Rex; Alan Thorson; Sidney J Winawer Journal: CA Cancer J Clin Date: 2008-03-05 Impact factor: 508.702
Authors: S J Winawer; A G Zauber; M N Ho; M J O'Brien; L S Gottlieb; S S Sternberg; J D Waye; M Schapiro; J H Bond; J F Panish Journal: N Engl J Med Date: 1993-12-30 Impact factor: 91.245
Authors: Bryan J M van de Wall; Ellen M B P Reuling; Esther C J Consten; Janneke H J van Grinsven; Matthijs P Schwartz; Ivo A M J Broeders; Werner A Draaisma Journal: Int J Colorectal Dis Date: 2012-03-13 Impact factor: 2.571
Authors: Robert H Fletcher; Marion R Nadel; John I Allen; Jason A Dominitz; Douglas O Faigel; David A Johnson; Dorothy S Lane; David Lieberman; John B Pope; Michael B Potter; Deborah P Robin; Paul C Schroy; Robert A Smith Journal: J Gen Intern Med Date: 2010-08-12 Impact factor: 5.128
Authors: Douglas K Rex; Philip S Schoenfeld; Jonathan Cohen; Irving M Pike; Douglas G Adler; M Brian Fennerty; John G Lieb; Walter G Park; Maged K Rizk; Mandeep S Sawhney; Nicholas J Shaheen; Sachin Wani; David S Weinberg Journal: Am J Gastroenterol Date: 2014-12-02 Impact factor: 10.864